Search

FROM ELDERDERM 2024 WASHINGTON--The chronic, excessive fragility of aging and sun-damaged skin has a name in the medical literature: dermatoporosis. This identification is helpful because it validates patients' suffering and [...]

WASHINGTON -- In 2013, Vishal A. Patel, MD, was completing a fellowship in Mohs surgery and cutaneous oncology at Columbia University Medical Center, New York City, when a study was [...]

Patients with psoriatic disease have significantly higher risks of myocardial infarction, stroke, and cardiovascular mortality than does the general population, yet research consistently paints what dermatologist Joel M. Gelfand, MD, [...]

WASHINGTON, DC -- Cutaneous immune related adverse events (cirAEs) in oncology patients receiving immune checkpoint inhibitors (ICIs) should be treated in as targeted a fashion as possible and with judicious [...]

WASHINGTON -- Immunoglobulin E (IgE) and eosinophils appeared to be reliable biomarkers of type 2 inflammation in chronic pruritus of unknown origin (CPUO) and predictors of a positive response to [...]

FROM ELDERDERM 2024 WASHINGTON--The onset of atopic dermatitis (AD) in older adulthood --even in adults aged [greater than or equal to] 90 years--is a phenomenon documented in the literature in [...]

WASHINGTON -- Atopic dermatitis (AD) in childhood presents most commonly by age 1 and typically begins on the face and, while it can make infants 'miserable,' caregiver and provider concerns [...]

A REVIEW of the literature on climate change and atopic dermatitis (AD) found evidence of a broad and negative impact of climatic hazards on various aspects of AD, including prevalence, [...]

Dietary supplements have a role in the integrative treatment of vitiligo, largely through antioxidant pathways and as an adjuvant to phototherapy, Ammar Ahmed, MD, associate professor of dermatology at Dell [...]

FROM JAMA DERMATOLOGY SPIRONOLACTONE was not associated with any meaningful increase in the risk of breast cancer or other solid-organ cancers in a systematic review and meta-analysis covering seven observational [...]

Isotretinoin was not associated with a 1-year risk of incident inflammatory bowel disease in a large population-based cohort study that also found no significant association of oral tetracycline-class antibiotics with [...]

WASHINGTON -- Multiple biologic failure in a minority of patients with psoriasis may have several causes, from genetic endotypes and immunologic factors to lower serum drug levels, the presence of [...]

WASHINGTON -- A series of three higher-than-approved induction doses of the interleukin-23 inhibitor risankizumab in patients with psoriasis--and no further subsequent dosing--led to an 'unprecedented' level of complete skin clearance [...]

WASHINGTON -- What does shared decision-making about atopic dermatitis (AD) treatment mean at a time of increasing treatment options and patient concerns about drug safety and the potentially lifelong need [...]

WASHINGTON -- The approval of the interleukin (ID36 receptor antagonist spesolimab for treating generalized pustular psoriasis flares in 2022 brightened the treatment landscape for this rare condition, and a recently [...]

A teledermatology clinic program established in Ward 8 of Washington, D.C., to help residents learn about and initiate care for atopic dermatitis (AD) has garnered high patient satisfaction marks and [...]

Ateledermatology clinic program established in Ward 8 of Washington to help residents learn about and initiate care for atopic dermatitis (AD) has garnered high patient satisfaction marks and may serve [...]

Judy C. Washington, MD, a mentor of many young academic family physicians, particularly underrepresented-in-medicine (URM) physicians, advises her mentees on how to see ahead and plot paths to leadership. For [...]

WASHINGTON -- Lebrikizumab, an interleukin (IL)-13 inhibitor under investigation for adults and adolescents with moderate to severe atopic dermatitis (AD), was efficacious in improving facial and hand dermatitis in a [...]

Children with atopic dermatitis (AD) were significantly more likely to have positive patch test results than were children without AD, according to a study of over 900 children evaluated for [...]

WASHINGTON -- A substantial proportion of adults with moderate to severe atopic dermatitis (AD) treated with oral abrocitinib 100 mg or 200 mg once daily for up to 96 weeks [...]

Climate change will increasingly affect the distribution and frequency of insect-borne diseases, cutaneous leishmaniasis, skin cancer, fungal diseases, and a host of other illnesses that have cutaneous manifestations or involve [...]

THE INCIDENCE OF ACNE in preadolescents was higher in girls than in boys, and was associated with higher body mass index (BMI) percentiles, in a large population-based retrospective study that [...]

A new drug application for a first-in-class photodynamic therapy (PDT) for treating early-stage cutaneous T-cell lymphoma (CTCL) has been submitted to the Food and Drug Administration based on phase 3 [...]

The evidence for an association between small-intestinal bacterial overgrowth (SIBO) and rosacea is strong enough to warrant consideration of the gastrointestinal condition in the treatment of rosacea, according to speakers [...]

Stephanie Flores-Pollack, MD, a dermatology resident at the University of Pennsylvania, Philadelphia, began considering the field of dermatology when, as part of the Latino Medical Students Association, she was invited [...]

Peter A. Lio, MD, is a big user of the 'big guns' for his patients with atopic dermatitis (AD)--biologies, conventional immunosuppressants, and Janus kinase (JAK) inhibitors. But he also has [...]

A commentary published across four dermatology journals in September urges dermatologists and their medical societies to 'engage more meaningfully' on climate change issues, 'moving beyond merely discussing skin-related impacts' and [...]

For much of the past 50 years, many of the drugs used in dermatology have been adopted --and often adapted--from other specialties and used for dermatologic conditions. 'Almost every drug [...]

High-dose vitamin D led to improvement of toxic erythema of chemotherapy (TEC) within 1-4 days in a retrospective case series of six patients seen on an inpatient dermatology consultative service. [...]

A TOPICAL GEL that contains birch bark extract as the active ingredient--Filsuvez (Oleogel-S10)--has been recommended for approval for the treatment of partial-thickness wounds associated with dystrophic and junctional epidermolysis bullosa [...]

AN INVESTIGATIVE SYNTHETIC cannabinoid receptor type 2 (CB2) agonist, lenabasum, was associated with greater improvements than placebo in patients with skin-predominant dermatomyositis--some of it statistically significant--in a phase 2, double-blind, [...]

The evidence for an association between small-intestinal bacterial overgrowth (SIBO) and rosacea is strong enough to warrant consideration of the gastrointestinal condition in the treatment of rosacea, according to speakers [...]

Fragmented, essentializing, simplistic. That's how students at Perelman School of Medicine at the University of Pennsylvania, Philadelphia, described their required course on cultural competence. Lectures and discussions about cultural groups [...]

Global climate change is hitting home for dermatologists, according to a recent survey in which the majority of participants said their patients are already being impacted. Almost 80% of the [...]